Literature DB >> 23872563

Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiome.

Alejandro A Pezzulo1, Patrick H Kelly, Boulos S Nassar, Cedric J Rutland, Nicholas D Gansemer, Cassie L Dohrn, Andrew J Costello, David A Stoltz, Joseph Zabner.   

Abstract

Human lungs are constantly exposed to bacteria in the environment, yet the prevailing dogma is that healthy lungs are sterile. DNA sequencing-based studies of pulmonary bacterial diversity challenge this notion. However, DNA-based microbial analysis currently fails to distinguish between DNA from live bacteria and that from bacteria that have been killed by lung immune mechanisms, potentially causing overestimation of bacterial abundance and diversity. We investigated whether bacterial DNA recovered from lungs represents live or dead bacteria in bronchoalveolar lavage (BAL) fluid and lung samples in young healthy pigs. Live bacterial DNA was DNase I resistant and became DNase I sensitive upon human antimicrobial-mediated killing in vitro. We determined live and total bacterial DNA loads in porcine BAL fluid and lung tissue by comparing DNase I-treated versus untreated samples. In contrast to the case for BAL fluid, we were unable to culture bacteria from most lung homogenates. Surprisingly, total bacterial DNA was abundant in both BAL fluid and lung homogenates. In BAL fluid, 63% was DNase I sensitive. In 6 out of 11 lung homogenates, all bacterial DNA was DNase I sensitive, suggesting a predominance of dead bacteria; in the remaining homogenates, 94% was DNase I sensitive, and bacterial diversity determined by 16S rRNA gene sequencing was similar in DNase I-treated and untreated samples. Healthy pig lungs are mostly sterile yet contain abundant DNase I-sensitive DNA from inhaled and aspirated bacteria killed by pulmonary host defense mechanisms. This approach and conceptual framework will improve analysis of the lung microbiome in disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872563      PMCID: PMC3811377          DOI: 10.1128/AEM.01752-13

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  41 in total

1.  The role of the lung microbiome in health and disease. A National Heart, Lung, and Blood Institute workshop report.

Authors:  Yvonne J Huang; Emily S Charlson; Ronald G Collman; Sandra Colombini-Hatch; Fernando D Martinez; Robert M Senior
Journal:  Am J Respir Crit Care Med       Date:  2013-06-15       Impact factor: 21.405

2.  Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia.

Authors:  A Torres; J Puig de la Bellacasa; A Xaubet; J Gonzalez; R Rodríguez-Roisin; M T Jiménez de Anta; A Agustí Vidal
Journal:  Am Rev Respir Dis       Date:  1989-08

3.  [Composting facilities. 2. Aerogenic microorganism content at different working areas of composting facilities].

Authors:  E Jager; H Rüden; B Zeschmar-Lahl
Journal:  Zentralbl Hyg Umweltmed       Date:  1994-12

4.  Pseudomonas aeruginosa produces an extracellular deoxyribonuclease that is required for utilization of DNA as a nutrient source.

Authors:  Heidi Mulcahy; Laetitia Charron-Mazenod; Shawn Lewenza
Journal:  Environ Microbiol       Date:  2010-03-29       Impact factor: 5.491

5.  Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.

Authors:  Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

6.  Spatial distribution of microbial communities in the cystic fibrosis lung.

Authors:  Dana Willner; Matthew R Haynes; Mike Furlan; Robert Schmieder; Yan Wei Lim; Paul B Rainey; Forest Rohwer; Douglas Conrad
Journal:  ISME J       Date:  2011-07-28       Impact factor: 10.302

7.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

8.  Airway surface liquid contains endogenous DNase activity which can be activated by exogenous magnesium.

Authors:  Joseph Rosenecker; S Naundorf; C Rudolph
Journal:  Eur J Med Res       Date:  2009-07-22       Impact factor: 2.175

9.  Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation.

Authors:  Leopoldo N Segal; Alexander V Alekseyenko; Jose C Clemente; Rohan Kulkarni; Benjamin Wu; Zhan Gao; Hao Chen; Kenneth I Berger; Roberta M Goldring; William N Rom; Martin J Blaser; Michael D Weiden
Journal:  Microbiome       Date:  2013-07-01       Impact factor: 14.650

10.  CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo.

Authors:  Pascal Knuefermann; Georg Baumgarten; Alexander Koch; Markus Schwederski; Markus Velten; Heidi Ehrentraut; Jan Mersmann; Rainer Meyer; Andreas Hoeft; Kai Zacharowski; Christian Grohé
Journal:  Respir Res       Date:  2007-10-09
View more
  21 in total

Review 1.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 2.  Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.

Authors:  Leopoldo N Segal; William N Rom; Michael D Weiden
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 3.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

4.  Dead or alive: Deoxyribonuclease I sensitive bacteria and implications for the sinus microbiome.

Authors:  Amanda L Willis; Joshua B Calton; Tara F Carr; Alexander G Chiu; Eugene H Chang
Journal:  Am J Rhinol Allergy       Date:  2015-12-28       Impact factor: 2.467

Review 5.  The innate immune function of airway epithelial cells in inflammatory lung disease.

Authors:  Pieter S Hiemstra; Paul B McCray; Robert Bals
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

6.  An investigation of canine leptospiral antibodies in Tokyo and Yokohama. Comparison of Canine Positive rates between rapid microscopic agglutination test and Schüffner-Mochtar test.

Authors:  E Ryu; A Hasegawa; S Saegusa; H Ichiki
Journal:  Int J Zoonoses       Date:  1974-12

7.  The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography.

Authors:  Katrine L Whiteson; Barbara Bailey; Megan Bergkessel; Douglas Conrad; Laurence Delhaes; Ben Felts; J Kirk Harris; Ryan Hunter; Yan Wei Lim; Heather Maughan; Robert Quinn; Peter Salamon; James Sullivan; Brandie D Wagner; Paul B Rainey
Journal:  Am J Respir Crit Care Med       Date:  2014-06-01       Impact factor: 21.405

Review 8.  Trachoma and Ocular Chlamydial Infection in the Era of Genomics.

Authors:  Tamsyn Derrick; Chrissy h Roberts; Anna R Last; Sarah E Burr; Martin J Holland
Journal:  Mediators Inflamm       Date:  2015-09-03       Impact factor: 4.711

9.  The microbiome of the human lower airways: a next generation sequencing perspective.

Authors:  Velma T E Aho; Pedro A B Pereira; Tari Haahtela; Ruby Pawankar; Petri Auvinen; Kaisa Koskinen
Journal:  World Allergy Organ J       Date:  2015-06-16       Impact factor: 4.084

10.  Biogeochemical forces shape the composition and physiology of polymicrobial communities in the cystic fibrosis lung.

Authors:  Robert A Quinn; Yan Wei Lim; Heather Maughan; Douglas Conrad; Forest Rohwer; Katrine L Whiteson
Journal:  MBio       Date:  2014-03-18       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.